Literature DB >> 7436611

Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients.

E A Gaensler, C B Carrington.   

Abstract

Clinical, physiological, roentgenographic, and histological data concerning 502 patients who had open biopsy for chronic "interstitial" lung disease were reviewed. Mortality was 0.3%, the rate of complications was 2.5%, and the diagnostic yield was 92.2%. A modified Chamberlain approach in the second interspace is preferred for easy access to all lobes and mediastinum. Brief tube drainage is mandatory. Atelectasis and hemorrhage in the specimen are prevented by avoiding palpation and clamps, by delineating the wedge during full inflation, and by instant fixation. Customary biopsies of the tip of the lingula or middle lobe are avoided because these are common sites of inflammation, scarring, and passive congestion. Often, the most abnormal regions are biopsied apparently to aid the pathologist. Such selection has been the most important cause of meaningless histological findings and poor pathological, physiological, and roentgenographic correlations because these regions usually show end-stage disease of unrecognizable origin. Average lung is more likely to show an active and recognizable process.

Entities:  

Mesh:

Year:  1980        PMID: 7436611     DOI: 10.1016/s0003-4975(10)61291-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  39 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

4.  Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease.

Authors:  Juan J Fibla; Alessandro Brunelli; Stephen D Cassivi; Claude Deschamps
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-17

Review 5.  Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias.

Authors:  Michael B Gotway; Michelle M Freemer; Talmadge E King
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

6.  Chest diseases-important advances in clinical medicine: invasive diagnostic approaches to pulmonary infiltrates.

Authors:  T A Raffin
Journal:  West J Med       Date:  1984-01

Review 7.  Biopsies in patients with intrathoracic disease.

Authors:  G A Lillington; W SooHoo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

Review 8.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

9.  Spontaneous pneumothorax in a case of pulmonary langerhans cell histiocytosis.

Authors:  Adrian Ciuche; Claudiu Nistor; Daniel Pantile; Dragos Marin; Augustin Tudose
Journal:  Maedica (Bucur)       Date:  2011-07

10.  Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.

Authors:  José Luis López-Campos; Eulogio Rodríguez-Becerra
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.